Aclaris Therapeutics is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Aclaris Therapeutics is a company founded in 2013 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Aclaris Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for dermatological and other medical conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.